"Aerpio Pharmaceuticals, Quantum to Evaluate Razuprotafib in New Study Under COVID-19 Program"
ARPO getting a lot of PM attention. This has the potential to have a large run. Looks like a gap from 1.50s to the 3.50-4 area. This will be my top watch today.
@Crispier-Bacon IMHO I know some people are only interested for the short term pop, but I see big potential in ARPO. Seems like they could be a major player in treating COVID-19. Vaccines don't always work in the long run as viruses mutate frequently. You need solid treatment. ARPO is on the cusp of something big. What's your thoughts for price action on Friday/Monday? What do you place the value of the company at currently?? thanks
Crispier-Bacon
⋅
@BinSF, this could have some huge potential. I know they currently market the drug they are testing for use as a treatment for covid related blood disorders. As of now it is used to treat glaucoma. With that in mind they should be able to bring a viable product to the table even faster. IF it works. That’s a big if. So I would rather buy into the covid rumor and watch for a gap fill to $4 area.
I don’t think we will have much action Friday. I would be watching for accumulation for a move Monday. After that it’s a waiting game for more PR. Probably still going to be a while for any real test data to show if this drug will actually be useful.